Provectus Biopharmaceuticals, Inc. announced that it has appointed Brendan O'Brien to its strategic advisory board. Brendan O'Brien is currently VP of Strategic Planning & Analysis for North American Pharmaceuticals at Sanofi. In this role, he is responsible for business planning and strategy development; he leads both the three-year strategic planning and one-year operating planning processes for Sanofi US, the North American affiliate of Sanofi SA.